No, GuruGary. And as far as quality of life they had already gone through chemorad. There are no NWBO trials involving Poly or anything else so until that happens I wouldn’t even consider it. Also SOC+ survival figures have likely gotten better since the trials initiation. Some article say 5 year survival is now 10% so no doubt 48 month mark is better too.
Survival at 48 months from randomization was 15.7% vs 9.9%, and at 60 months, it was 13.0% vs 5.7%.
Market Data 
Markets 
AI
